ADMA Biologics (ADMA) Institutional Ownership
13F filers reported holding 93.4% of ADMA Biologics (ADMA) shares as of Jun 30, 2026, across 324 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 93.4%
- Jun 30, 2026
- 13F filers
- 324
- quarter ended Jun 30, 2026
- 13F value
- $1.7B
- 207.3M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Grossman Adam S | President and CEO | Acquired · Option exercise | 105,000 | $5.40 | ↗ |
| Nov 5, 2026 | Grossman Adam S | President and CEO | Disposed · Open-market sale | 105,000 | $12.00 | ↗ |
| Nov 5, 2026 | Grossman Adam S | President and CEO | Disposed · Open-market sale | 42,000 | $12.00 | ↗ |
| Nov 5, 2026 | Grossman Adam S | President and CEO | Disposed · Option exercise | 105,000Stock Option (Right to Buy) | — | ↗ |
| Jul 24, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Disposed · Tax withholding | 3,177 | $8.37 | ↗ |
| Jul 16, 2026 | Kohler Terry | CFO and Treasurer | Acquired · Grant / award | 85,130 | — | ↗ |
| Jul 16, 2026 | Kohler Terry | CFO and Treasurer | Acquired · Grant / award | 136,363Stock Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Grossman Jerrold B | director | Acquired · Open-market buy | 6,400 | $7.91 | ↗ |
| May 12, 2026 | Grossman Jerrold B | director | Acquired · Open-market buy | 12,500 | $8.01 | ↗ |
| May 11, 2026 | Grossman Jerrold B | director | Acquired · Open-market buy | 12,500 | $8.01 | ↗ |
| Apr 1, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Disposed · Tax withholding | 20,362 | $9.11 | ↗ |
| Mar 17, 2026 | Guiheen Lawrence P. | director | Disposed · Gift | 30,000 | — | ↗ |
| Mar 17, 2026 | Guiheen Lawrence P. | director | Acquired · Gift | 30,000 | — | ↗ |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Acquired · Option exercise | 15,000 | $5.40 | ↗ |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Disposed · Open-market sale | 15,000 | $15.16 | ↗ |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Disposed · Open-market sale | 6,000 | $15.16 | ↗ |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Disposed · Option exercise | 15,000Stock Option (right to buy) | — | ↗ |
| Mar 13, 2026 | Guiheen Lawrence P. | director | Acquired · Option exercise | 30,000 | $3.66 | ↗ |
| Mar 13, 2026 | Guiheen Lawrence P. | director | Disposed · Option exercise | 30,000Stock Option (Right to Buy) | — | ↗ |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Disposed · Other | 91,266 | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of ADMA Biologics do institutions hold?
13F filers reported holding 93.4% of ADMA Biologics' shares as of Jun 30, 2026, across 324 filers.
How many 13F filers hold ADMA Biologics?
ADMA Biologics was held by 324 13F filers as of Jun 30, 2026.
Not investment advice.

